YY/T 0688.1-2023Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 1: Reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases (English PDF)
感染病原体敏感性试验与抗微生物药物敏感性试验设备的性能评价 第1部分:抗微生物药物对感染性疾病快速生长需氧菌的体外活性检测的参考方法
This is a limited preview
Buy now to download the full PDF (22 pages)
Need quotation for your management?
Get a formal quotation for YY/T 0688.1-2023 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
March 14, 2023
Implementation date
November 1, 2023
Scope
YY/T 0688.1-2023 is the English-translated version of 感染病原体敏感性试验与抗微生物药物敏感性试验设备的性能评价 第1部分:抗微生物药物对感染性疾病快速生长需氧菌的体外活性检测的参考方法.
YY/T 0688.1-2023 is the Chinese standard "Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 1: Reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases".
Its scope clause reads: This document describes a reference method for the determination of MIC values for antimicrobial drugs - the broth microdilution method: MIC value can give doctors As a guide, which reflects the antimicrobial activity of an antimicrobial under defined in vitro test conditions, considerations such as drug pharmacology, Other factors such as pharmacokinetics or mechanisms of bacterial resistance: This allows bacteria to be classified as "susceptible (S)", "intermediate (I)" or "resistant (R)": Other In addition, the distribution of MIC values can be used to determine wild-type or non-wild-type bacterial communities: Although the clinical interpretation of MIC values is beyond the scope of this document range, but adjustments to the basic approach for some antimicrobial-bacteria combinations are necessary for clinical interpretation: These tweak packs Included in a separate appendix to this document: In order to ensure the comparability and reliability of test results, other drug susceptibility test methods (such as disk diffusion method or Diagnostic test equipment) It is necessary to compare with this reference method for confirmation: This document applies to the determination of MIC values using the broth microdilution method:. Its clauses include terms and definitions.
Found what you need?
Document preview — YY/T 0688.1-2023
National Standard of the People's Republic of China
- ICS
- 11.100/10
- Classification
- C30
- Replacing
- YY/T 0688.1-2008
Issued by: National Medical Products Administration
Contents
- Preface
- Introduction
- 1 Scope
- 2 Normative references
- 3 Terms and Definitions
- 4 Test procedure
- 5 Quality Control
- Appendix A (Informative) Mueler-Hinton Broth Medium
- Appendix B (informative) Solvents and diluents for the preparation of stock solutions of specific antimicrobial drugs
- Appendix D (informative) Special test conditions
1 Scope
This document describes a reference method for the determination of MIC values for antimicrobial drugs - the broth microdilution method: MIC value can give doctors
As a guide, which reflects the antimicrobial activity of an antimicrobial under defined in vitro test conditions, considerations such as drug pharmacology,
Other factors such as pharmacokinetics or mechanisms of bacterial resistance: This allows bacteria to be classified as "susceptible (S)", "intermediate (I)" or "resistant (R)": Other
In addition, the distribution of MIC values can be used to determine wild-type or non-wild-type bacterial communities: Although the clinical interpretation of MIC values is beyond the scope of this document range, but adjustments to the basic approach for some antimicrobial-bacteria combinations are necessary for clinical interpretation: These tweak packs
Included in a separate appendix to this document: In order to ensure the comparability and reliability of test results, other drug susceptibility test methods (such as disk diffusion method or
Diagnostic test equipment) It is necessary to compare with this reference method for confirmation:
This document applies to the determination of MIC values using the broth microdilution method:
2 Normative references
This document has no normative references:
3 Terms and Definitions
The following terms and definitions apply to this document:
3:1 antimicrobial agent
A class of biologically derived, semi-synthetic or synthetic substances that inhibit or kill microorganisms and may be used in anti-infective therapy:
Note: Disinfectants, sterilants and antiseptics are not within the scope of this definition:
3:2 potency
A measure of the activity of a drug, expressed in terms of the amount required to produce a drug effect of a given strength:
Note: Potency can be expressed as the mass fraction of the components in the test substance in milligrams per gram (mg/g), or the active content in international units per gram (IU/g), or in terms of volume
The percentage content of fraction or mass fraction or the concentration of a substance in moles per liter (mol fraction):
3:3
Concentration concentration
The amount of antimicrobial drug in a defined volume of solution:
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 22 pages — is available in the English PDF.
Referenced standards
Cited by
- YY/T 0688.2-2024Clinical laboratory testing and in vitro diagnostic test systems-Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 2 : Evaluation of performance of antimicrobial susceptibility test devices against reference broth micro-dilution
- GB/T 40672-2021Clinical laboratory testing - Criteria for acceptable lots of dehydrated Mueller-Hinton agar and broth for antimicrobial susceptibility testing
Editions of YY/T 0688.1
| Edition | Title | Revision | Status |
|---|---|---|---|
| YY/T 0688.1-2023 | Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 1: Reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases | current edition | Current |
| YY/T 0688.1-2008 | Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 1: Reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases | previous edition | In force until 2023-11-01 |
This page sells the current edition, YY/T 0688.1-2023. Earlier editions are listed for reference only.
How to Download YY/T 0688.1-2023
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
YY/T 0688.2-2024 — Clinical laboratory testing and in vitro diagnostic test systems-Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 2 : Evaluation of performance of antimicrobial susceptibility test devices against reference broth micro-dilution
YY/T 0688.2-2010 — Clinical laboratory testing and in vitro diagnostic test systems - Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 2: Evaluation of performance of antimicrobial susceptibility test devices
YY/T 0688.1-2008 — Clinical laboratory testing and in vitro diagnostic test systems - Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 1: Reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases
Secure payment via Stripe
Payments accepted
YY/T 0688.1-2023
$330.00